The Proposed Waivers Of The Fraud & Abuse Laws For ACOs: Have OIG And CMS Gone Far Enough?

MW
McDermott Will & Emery

Contributor

McDermott Will & Emery logo
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 1,100 lawyers across several office locations worldwide, our team works seamlessly across practices, industries and geographies to deliver highly effective solutions that propel success.
While the proposed ACO waivers of the fraud and abuse laws go far in reconciling the goals of the Medicare Shared Savings Program with the concerns of the fraud and abuse laws, broader and additional waivers are needed to allow ACOs to operate effectively.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

While the proposed ACO waivers of the fraud and abuse laws go far in reconciling the goals of the Medicare Shared Savings Program with the concerns of the fraud and abuse laws, broader and additional waivers are needed to allow ACOs to operate effectively.

Please click here to view the entire White Paper in Adobe PDF format.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More